LigoCyte, Biogen Idec to jointly develop anti-inflammatory treatment
| September 18, 2007 |  View for printing |
LigoCyte Pharmaceuticals Inc http://www.ligocyte.com/ said it and biotechnology group Biogen Idec Inc http://www.biogenidec.com/ have agreed to jointly develop anti-inflammatory drugs.
http://www.sharewatch.com/story.php?storynumber=28257 
No reader comments so far. Be the first to comment by clicking the button below.
Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.
